184 related articles for article (PubMed ID: 12271881)
21. Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs.
Rahme E; Joseph L; Kong SX; Watson DJ; Pellissier JM; LeLorier J
Pharmacoeconomics; 2001; 19(5 Pt 2):577-88. PubMed ID: 11465302
[TBL] [Abstract][Full Text] [Related]
22. Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.
Al MJ; Maniadakis N; Grijseels EW; Janssen M
Value Health; 2008; 11(4):589-99. PubMed ID: 18194404
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.
Chancellor JV; Hunsche E; de Cruz E; Sarasin FP
Pharmacoeconomics; 2001; 19 Suppl 1():59-75. PubMed ID: 11280106
[TBL] [Abstract][Full Text] [Related]
24. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
26. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
Davis R; Yarker YE; Goa KL
Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992
[TBL] [Abstract][Full Text] [Related]
27. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
[TBL] [Abstract][Full Text] [Related]
28. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
29. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
McCarthy DM
Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
[TBL] [Abstract][Full Text] [Related]
30. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
31. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
32. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
[TBL] [Abstract][Full Text] [Related]
33. Diclofenac/misoprostol: novel findings and their clinical potential.
Shield MJ
J Rheumatol Suppl; 1998 May; 51():31-41. PubMed ID: 9596552
[TBL] [Abstract][Full Text] [Related]
34. Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.
Lanas A
Aliment Pharmacol Ther; 2004 Aug; 20(3):321-31. PubMed ID: 15274669
[TBL] [Abstract][Full Text] [Related]
35. A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis.
Burke TA; Zabinski RA; Pettitt D; Maniadakis N; Maurath CJ; Goldstein JL
Pharmacoeconomics; 2001; 19 Suppl 1():33-47. PubMed ID: 11280104
[TBL] [Abstract][Full Text] [Related]
36. An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada.
Zabinski RA; Burke TA; Johnson J; Lavoie F; Fitzsimon C; Tretiak R; Chancellor JV
Pharmacoeconomics; 2001; 19 Suppl 1():49-58. PubMed ID: 11280105
[TBL] [Abstract][Full Text] [Related]
37. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
Pope JE; Prashker M; Anderson J
J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
[TBL] [Abstract][Full Text] [Related]
39. [Is misoprostol effective in NSAID-induced gastrointestinal complications?].
Stucki G; Sangha O; Michel BA
Schweiz Med Wochenschr; 1996 Sep; 126(37):1573-8. PubMed ID: 8927962
[TBL] [Abstract][Full Text] [Related]
40. Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study.
Munger MA; Gardner SF; Ateshkadi A; Rabetoy GM; Barri YM; Stoddard GJ; Cheung AK;
Pharmacotherapy; 2008 Jul; 28(7):834-42. PubMed ID: 18576898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
